Search
Search Results
##search.searchResults.foundPlural##
-
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1103PDF: 457HTML: 195 -
WHAT ARE FUNGAL INFECTIONS?
4027PDF: 2307HTML: 27547de Pauw: 205 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3144PDF: 1679HTML: 1071 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1108PDF: 582HTML: 6780 -
Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation Inflammatory marker elevation in MDS
804PDF: 616HTML: 187 -
I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS
1057PDF: 448HTML: 286 -
-
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3466PDF: 1032HTML: 864 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1189PDF: 838HTML: 1093Coverletter: 175 -
EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome
667PDF: 378HTML: 69 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2076PDF: 1295HTML: 3486 -
COEXISTENCE OF MULTIPLE GENE VARIANTS IN SOME PATIENTS WITH ERYTHROCYTOSES Multiple gene variants in erythrocytosis
776PDF: 1193HTML: 115 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
679PDF: 470Suppl. Files: 104HTML: 76 -
-
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1083PDF: 875HTML: 280 -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2711PDF: 723HTML: 1242Blood Count trend before and during lenalidomide treatment: 154Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 169 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1244PDF: 981HTML: 108 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3124PDF: 1018HTML: 411 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1751HTML: 1358PDF: 1025 -
How I treat acute and persistent sickle cell pain
1835PDF: 1087HTML: 457 -
FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS Outcomes of ASCT in NDMM elderly fit patients
1016PDF: 589Html: 134 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
928PDF: 513HTML: 711 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
736PDF: 466HTML: 92 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1111PDF: 799HTML: 2164Figue 1: 157 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
889PDF: 558HTML: 2177Cover Letter: 172 -







